BiotechTube
Bone Solutions

Bone Solutions

Dallas, United States· Est.
bonesolutions.net
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Bone Solutions is a private, commercial-stage company that has developed a differentiated orthopedic bone graft substitute based on magnesium chemistry. Its core technology leverages magnesium's inherent biological role in bone health to create a cohesive, adhesive, and radiopaque material that sets quickly and is fully resorbable. The company appears to be in an early revenue-generating phase, actively marketing its product to surgeons and engaging in key orthopedic conferences to drive adoption in complex revision and trauma cases. Its business model is focused on the therapeutic application of its material as an implantable medical device.

OrthopedicsTraumaSpine

Technology Platform

Magnesium-based synthetic bone graft substitute platform. The material is moldable/injectable, sets in 2 minutes, is drillable, cohesive/adhesive, radiopaque, and fully resorbable. It leverages magnesium's role in enhancing osteoblast activity and bone mineralization.

Funding History

2
Total raised:$2.5M
Seed$2M
Grant$500K

Opportunities

The growing volume of complex revision joint arthroplasties and aging-related fractures presents a sustained need for better bone graft materials.
Magnesium's biological benefits and the product's superior handling properties provide a clear differentiation to capture share in the synthetic bone graft market.
Strategic partnership or acquisition by a larger orthopedic company is a potential exit or growth accelerator.

Risk Factors

Intense competition from large, established medical device companies with broad sales forces and existing surgeon relationships.
Limited clinical data beyond testimonials may hinder widespread adoption and reimbursement.
As a small, private company, it faces financial constraints and execution risks in scaling commercial operations.

Competitive Landscape

Bone Solutions competes in the synthetic bone graft substitute market against dominant players like Stryker (Calstrux, Vitoss), Medtronic (Mastergraft), Zimmer Biomet (CopiOs), and Smith & Nephew, who primarily offer calcium phosphate, calcium sulfate, or bioactive glass materials. Its key differentiation is its magnesium-based chemistry, which claims superior adhesive/cohesive properties and resorption profile compared to traditional calcium-based cements.

More companies in Regenerative Medicine →More companies in United States →